WILLIAM JL RIEFLIN - 24 May 2023 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact for William Rieflin
Issuer symbol
RAPT
Transactions as of
24 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 19:00:34 UTC
Previous filing
12 May 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Stock Option (right to buy) Award $0 +12,940 $0.000000 12,940 24 May 2023 Common Stock 12,940 $20.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall vest on the earlier of (i) May 24, 2024, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2024, subject to the Reporting Person's continuous service through each applicable vesting date.